Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

NCT00967759 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was designed again in compliance with the regulatory agency.

Conditions

Common Cold

Interventions

DRUG: Bronpheniramine and fenilefrine (Decongex Plus)
DRUG: Bronpheniramine isolated
DRUG: Fenilefrine isolated

Sponsor

Ache Laboratorios Farmaceuticos S.A.